Breaking News Instant updates and real-time market news.

SYNH

Syneos Health

$46.50

(0.00%)

06:21
11/06/18
11/06
06:21
11/06/18
06:21

Syneos Health reports Q3 adjusted EPS 75c, consensus 68c

Reports Q3 adjusted revenue $1.12B, consensus $1.12B.

  • 06

    Nov

SYNH Syneos Health
$46.50

(0.00%)

10/09/18
UBSW
10/09/18
INITIATION
Target $60
UBSW
Buy
Syneos Health initiated with a Buy at UBS
UBS analyst Daniel Brennan initiated Syneos Health with a Buy rating and $60 price target.
10/09/18
UBSW
10/09/18
NO CHANGE
UBSW
UBS initiates coverage of Life Sciences and Diagnostics Tools sector
UBS analyst Daniel Brennan initiated coverage of the Life Sciences and Diagnostics Tools sector. He said demand is accelerating across his universe but valuations are extended. He expects strong fundamentals to continue into 2019 but he said selectivity is the key. In the group, his Buy ratings include Exact Sciences (EXAS), Iqvia (IQV), NanoString (NSTG), Syneos Health (SYNH) and Thermo Fisher (TMO).
10/19/18
WBLR
10/19/18
UPGRADE
WBLR
Outperform
Syneos Health upgraded to Outperform from Market Perform at William Blair
William Blair analyst John Kreger upgraded Syneos Health to Outperform.
10/19/18
WBLR
10/19/18
UPGRADE
WBLR
Outperform
William Blair upgrades Syneos to Outperform on improved risk/reward
William Blair analyst John Kreger upgraded Syneos Health to Outperform from Market Perform citing an improved risk/reward at current share levels. After a "painful reset" in expectations last year amid the inVentiv merger integration, Syneos' operations have stabilized, particularly in the more volatile commercial segment, Kreger tells investors in a research note. When combined with a "robust demand environment" in clinical and an attractive relative valuation, the stock is "well positioned for a return of double-digit earnings growth next year and improved share price appreciation, "Kreger contends.

TODAY'S FREE FLY STORIES

08:50
02/19/19
02/19
08:50
02/19/19
08:50
Conference/Events
Cowen Washington research group to hold a meeting »

Cowen's Washington…

ECL

Ecolab

$163.45

1.82 (1.13%)

08:50
02/19/19
02/19
08:50
02/19/19
08:50
Earnings
Ecolab sees FY19 adj. EPS $5.80-$6.00, consensus $5.91 »

The outlook provided…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 20

    Feb

  • 11

    Mar

  • 11

    Mar

  • 12

    Mar

  • 13

    Mar

  • 14

    Mar

  • 20

    Mar

  • 21

    Mar

  • 22

    Mar

  • 28

    May

CRUS

Cirrus Logic

$40.00

0.85 (2.17%)

08:48
02/19/19
02/19
08:48
02/19/19
08:48
Conference/Events
Cirrus Logic management to meet with Cowen »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 20

    Feb

  • 21

    Feb

ECL

Ecolab

$163.45

1.82 (1.13%)

08:47
02/19/19
02/19
08:47
02/19/19
08:47
Earnings
Ecolab reports Q4 adj. EPS $1.54, consensus $1.54 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 20

    Feb

  • 11

    Mar

  • 11

    Mar

  • 12

    Mar

  • 13

    Mar

  • 14

    Mar

  • 20

    Mar

  • 21

    Mar

  • 22

    Mar

  • 28

    May

ORTX

Orchard Therapeutics

$15.08

0.58 (4.00%)

08:47
02/19/19
02/19
08:47
02/19/19
08:47
Conference/Events
Orchard Therapeutics management to meet with Cowen »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 20

    Feb

GSK

GlaxoSmithKline

$41.24

0.38 (0.93%)

08:46
02/19/19
02/19
08:46
02/19/19
08:46
Conference/Events
GlaxoSmithKline management to meet with Cowen »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 18

    May

GMDA

Gamida Cell

$13.25

0.3 (2.32%)

, EDIT

Editas Medicine

$20.09

0.22 (1.11%)

08:45
02/19/19
02/19
08:45
02/19/19
08:45
Hot Stocks
Gamida Cell, Editas Medicine announce agreement to evaluate use of CRISPR tech »

Gamida Cell (GMDA)…

GMDA

Gamida Cell

$13.25

0.3 (2.32%)

EDIT

Editas Medicine

$20.09

0.22 (1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

EXPD

Expeditors

$73.56

-0.45 (-0.61%)

08:45
02/19/19
02/19
08:45
02/19/19
08:45
Earnings
Expeditors reports Q4 EPS $1.02, consensus 85c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MPO

Midstates Petroleum

$9.25

-0.17 (-1.80%)

, AXDX

Accelerate Diagnostics

$19.82

0.65 (3.39%)

08:45
02/19/19
02/19
08:45
02/19/19
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

MPO

Midstates Petroleum

$9.25

-0.17 (-1.80%)

AXDX

Accelerate Diagnostics

$19.82

0.65 (3.39%)

WATT

Energous

$8.91

0.11 (1.25%)

CRON

Cronos Group

$21.28

0.46 (2.21%)

NIO

NIO Inc.

$7.41

-0.07 (-0.94%)

EPD

Enterprise Products

$28.21

0.01 (0.04%)

NBEV

New Age Beverages

$6.50

-0.08 (-1.22%)

ITB

iShares U.S. Home Construction ETF

$35.22

0.36 (1.03%)

CWH

Camping World

$15.11

-0.105 (-0.69%)

SAND

Sandstorm Gold

$5.49

0.06 (1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 21

    Feb

  • 22

    Feb

  • 27

    Feb

  • 04

    Mar

WBC

Wabco

$116.78

0.19 (0.16%)

08:44
02/19/19
02/19
08:44
02/19/19
08:44
Recommendations
Wabco analyst commentary  »

Baird would be aggressive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADVM

Adverum Biotechnologies

$3.80

0.28 (7.95%)

08:43
02/19/19
02/19
08:43
02/19/19
08:43
Conference/Events
Adverum Biotechnologies management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 22

    Feb

  • 27

    Feb

DPZ

Domino's Pizza

$281.63

-5.46 (-1.90%)

08:43
02/19/19
02/19
08:43
02/19/19
08:43
Recommendations
Domino's Pizza analyst commentary  »

Domino's Pizza price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 14

    Mar

08:42
02/19/19
02/19
08:42
02/19/19
08:42
Conference/Events
UBS pharmaceuticals analyst to hold an analyst/industry conference call »

Pharmaceuticals Analyst…

GVA

Granite Construction

$45.48

0.59 (1.31%)

08:42
02/19/19
02/19
08:42
02/19/19
08:42
Hot Stocks
Granite's Water and Mineral Services Group awarded $22.5M in sewer projects »

Granite announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

WWW

Wolverine World Wide

$39.54

0.94 (2.44%)

08:42
02/19/19
02/19
08:42
02/19/19
08:42
Recommendations
Wolverine World Wide analyst commentary  »

Fresh Pick designation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

MCEP

Mid-Con Energy

$0.98

0.06 (6.52%)

08:41
02/19/19
02/19
08:41
02/19/19
08:41
Hot Stocks
Mid-Con Energy sell Texas properties for $60M, buys Oklahoma assets for $27.5M »

Mid-Con Energy, through…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KTOS

Kratos Defense

$16.95

(0.00%)

08:41
02/19/19
02/19
08:41
02/19/19
08:41
Recommendations
Kratos Defense analyst commentary  »

Kratos Defense price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

PEP

PepsiCo

$115.89

3.4 (3.02%)

, KO

Coca-Cola

$45.25

-0.345 (-0.76%)

08:41
02/19/19
02/19
08:41
02/19/19
08:41
Upgrade
PepsiCo, Coca-Cola rating change  »

Macquarie upgrades…

PEP

PepsiCo

$115.89

3.4 (3.02%)

KO

Coca-Cola

$45.25

-0.345 (-0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 03

    Mar

  • 18

    May

HMST

HomeStreet

08:39
02/19/19
02/19
08:39
02/19/19
08:39
Recommendations
HomeStreet analyst commentary  »

HomeStreet price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSIC

Henry Schein

$62.38

0.03 (0.05%)

08:39
02/19/19
02/19
08:39
02/19/19
08:39
Recommendations
Henry Schein analyst commentary  »

Henry Schein price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

GPC

Genuine Parts

$107.49

1.7447 (1.65%)

08:39
02/19/19
02/19
08:39
02/19/19
08:39
Hot Stocks
Breaking Hot Stocks news story on Genuine Parts »

Genuine Parts sees FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 04

    Apr

AEO

American Eagle

$20.07

-0.03 (-0.15%)

08:39
02/19/19
02/19
08:39
02/19/19
08:39
Hot Stocks
American Eagle announces license agreement to expand brands to Europe »

American Eagle Outfitters…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

GPC

Genuine Parts

$107.49

1.7447 (1.65%)

08:37
02/19/19
02/19
08:37
02/19/19
08:37
Hot Stocks
Genuine Parts reports Q4 sales for Automotive Group up 11.4% »

Fourth quarter sales for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 04

    Apr

CHFS

CHF Solutions

$10.05

0.75 (8.06%)

08:37
02/19/19
02/19
08:37
02/19/19
08:37
Hot Stocks
CHF Solutions enters South American market with Bragenix distribution agreement »

CHF Solutions announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

MRVL

Marvell

$18.82

-0.37 (-1.93%)

08:37
02/19/19
02/19
08:37
02/19/19
08:37
Upgrade
Marvell rating change  »

Marvell upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Mar

  • 25

    Mar

  • 26

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.